ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is 2.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $41,000 | -18.0% | 2,195 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $50,000 | +8.7% | 2,195 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $46,000 | +84.0% | 2,195 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $25,000 | -50.0% | 2,195 | 0.0% | 0.00% | -42.9% |
Q3 2018 | $50,000 | +2.0% | 2,195 | 0.0% | 0.01% | -12.5% |
Q2 2018 | $49,000 | -99.9% | 2,195 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $50,156,000 | -12.8% | 2,195 | 0.0% | 0.01% | -11.1% |
Q4 2017 | $57,509,000 | +16.7% | 2,195 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $49,278,000 | -17.9% | 2,195 | 0.0% | 0.01% | -18.2% |
Q2 2017 | $60,033,000 | +13.0% | 2,195 | 0.0% | 0.01% | +10.0% |
Q1 2017 | $53,119,000 | +16.6% | 2,195 | 0.0% | 0.01% | +11.1% |
Q4 2016 | $45,546,000 | -23.9% | 2,195 | 0.0% | 0.01% | -30.8% |
Q3 2016 | $59,836,000 | +89.4% | 2,195 | 0.0% | 0.01% | +85.7% |
Q2 2016 | $31,586,000 | +10.9% | 2,195 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $28,469,000 | +72897.4% | 2,195 | +22.3% | 0.01% | -30.0% |
Q4 2015 | $39,000 | +30.0% | 1,795 | +12.5% | 0.01% | +11.1% |
Q3 2015 | $30,000 | – | 1,595 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
Miura Global Management | 435,000 | $8,348,000 | 0.63% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |